Disulfiram-Cu treatment induces apoptosis in TNBC cells by activating caspase-3 and selectively targeting cancer stem cell-like populations. These effects are associated with a significant disruption of the STAT3 signaling pathway. This evidence concerns the gene CASP3 and cancer.